Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Matthew L Sherman. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Matthew L Sherman har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
EVP & Chief Medical Officer | 0 | |
US:PIRS / Pieris Pharmaceuticals, Inc. | Director | 40 000 |
Director | 13 889 | |
US:PULM / Pulmatrix, Inc. | Director | 15 000 |
US:XLRN / Acceleron Pharma Inc | EVP & Chief Medical Officer | 68 767 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Matthew L Sherman. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp PULM / Pulmatrix, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i PULM / Pulmatrix, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2018-04-03 | PULM | Sherman Matthew L | 20 000 | 1 333 | 69 | 120 |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel PULM / Pulmatrix, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i PULM / Pulmatrix, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Matthew L Sherman som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-11 |
|
4 | NA |
Deciphera Pharmaceuticals, Inc.
Common Stock |
U - Other | −72 261 | 0 | −100,00 | ||||
2024-06-11 |
|
4 | NA |
Deciphera Pharmaceuticals, Inc.
Common Stock |
D - Sale to Issuer | −72 029 | 72 261 | −49,92 | ||||
2024-06-11 |
|
4 | NA |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 34 157 | 144 290 | 31,01 | ||||
2024-02-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 615 | 108 739 | −2,35 | 15,62 | −40 840 | 1 698 253 | |
2024-02-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 17 275 | 111 354 | 18,36 | ||||
2024-01-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 435 | 94 079 | −2,52 | 14,47 | −35 234 | 1 361 295 | |
2023-12-14 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 792 | 96 514 | −2,81 | 15,37 | −42 905 | 1 483 140 | |
2023-12-14 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 8 244 | 99 306 | 9,05 | ||||
2023-10-31 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 360 | 90 628 | −2,54 | 12,02 | −28 362 | 1 089 131 | |
2023-10-31 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 8 244 | 92 988 | 9,73 | ||||
2023-10-04 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 942 | 84 744 | −3,36 | 12,68 | −37 305 | 1 074 554 | |
2023-06-21 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −1 655 | 87 686 | −1,85 | 14,40 | −23 835 | 1 262 836 | |
2023-02-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −971 | 88 145 | −1,09 | 15,10 | −14 661 | 1 330 901 | |
2023-02-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 16 488 | 89 116 | 22,70 | ||||
2023-01-19 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 403 | 72 628 | −3,20 | 21,24 | −51 043 | 1 542 713 | |
2022-10-05 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 587 | 74 297 | −3,36 | 18,73 | −48 455 | 1 391 583 | |
2022-06-21 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −1 768 | 76 884 | −2,25 | 10,75 | −19 006 | 826 503 | |
2022-02-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −984 | 76 790 | −1,27 | 9,05 | −8 905 | 694 950 | |
2022-01-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 82 000 | 82 000 | |||||
2022-01-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 20 500 | 77 774 | 35,79 | ||||
2021-12-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 82 265 | 82 265 | |||||
2021-12-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 11 100 | 57 274 | 24,04 | ||||
2021-10-06 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 659 | 46 029 | −5,46 | 33,17 | −88 199 | 1 526 782 | |
2021-06-29 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
2021-02-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 49 900 | 49 900 | |||||
2021-02-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 11 100 | 48 386 | 29,77 | ||||
2021-02-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −132 | 37 286 | −0,35 | 48,87 | −6 451 | 1 822 167 | |
2020-12-11 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to buy) |
M - Exercise | −207 | 147 096 | −0,14 | ||||
2020-12-11 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 207 | 37 418 | 0,56 | 34,43 | 7 127 | 1 288 302 | |
2020-11-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to buy) |
M - Exercise | −2 697 | 147 303 | −1,80 | ||||
2020-11-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 2 697 | 37 211 | 7,81 | 34,43 | 92 858 | 1 281 175 | |
2020-10-06 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 632 | 34 128 | −7,16 | 51,15 | −134 618 | 1 745 535 | |
2020-06-25 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
2020-02-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | −10 520 | 10 520 | −50,00 | ||||
2020-02-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 1 760 | 36 760 | 5,03 | ||||
2020-01-28 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2019-10-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 150 000 | 150 000 | |||||
2019-10-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 35 000 | 35 000 | |||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 13 889 | 13 889 | |||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
D - Sale to Issuer | −27 777 | 0 | −100,00 | ||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 18 506 | 18 506 | |||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 13 218 | 13 218 | |||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
D - Sale to Issuer | −63 447 | 0 | −100,00 | ||||
2019-05-20 |
|
4 | PULM |
Pulmatrix, Inc.
Stock Option (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2019-05-14 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 25 000 | 25 000 | |||||
2019-01-29 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2018-10-25 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
2018-06-06 |
|
4 | PULM |
Pulmatrix, Inc.
Stock Option (Right to Buy) |
A - Award | 124 000 | 124 000 | |||||
2018-05-25 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 27 777 | 27 777 | |||||
2018-04-05 |
|
4 | PULM |
Pulmatrix, Inc.
Series A Warrant (right to buy) |
P - Purchase | 20 000 | 20 000 | |||||
2018-04-05 |
|
4 | PULM |
Pulmatrix, Inc.
Series B Warrant (right to buy) |
P - Purchase | 20 000 | 20 000 | |||||
2018-04-05 |
|
4 | PULM |
Pulmatrix, Inc.
Common Stock |
P - Purchase | 20 000 | 20 000 | |||||
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −900 | 68 767 | −1,29 | 39,04 | −35 136 | 2 684 664 |
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 700 | 69 667 | −5,04 | 38,28 | −141 636 | 2 666 853 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 033 | 73 367 | −2,70 | 43,33 | −88 090 | 3 178 992 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 300 | 75 400 | −2,96 | 42,40 | −97 520 | 3 196 960 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 77 700 | −0,38 | 40,86 | −12 258 | 3 174 822 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −150 | 78 000 | −0,19 | 39,91 | −5 986 | 3 112 980 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 78 150 | −2,01 | 39,24 | −62 784 | 3 066 606 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −16 650 | 79 750 | −17,27 | 38,32 | −638 028 | 3 056 020 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −8 000 | 0 | −100,00 | |||
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −16 000 | 96 400 | −14,23 | 32,00 | −512 000 | 3 084 800 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 8 000 | 112 400 | 7,66 | 7,12 | 56 960 | 800 288 |
2017-03-22 |
|
4 | PULM |
Pulmatrix, Inc.
Stock Option (Right to Buy) |
A - Award | 4 400 | 4 400 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 47 300 | 47 300 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 7 900 | 104 400 | 8,19 | ||||
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 96 500 | −1,63 | 27,62 | −44 192 | 2 665 330 |
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 98 100 | −0,41 | 26,81 | −10 724 | 2 630 061 |
2016-10-03 |
|
4 | PULM |
Pulmatrix, Inc.
Stock Option (Right to Buy) |
A - Award | 8 800 | 8 800 | |||||
2016-08-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −17 000 | 8 000 | −68,00 | ||||
2016-08-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −1 896 | 0 | −100,00 | ||||
2016-08-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 17 000 | 98 500 | 20,86 | 7,12 | 121 040 | 701 320 | |
2016-08-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 1 896 | 81 500 | 2,38 | 5,28 | 10 011 | 430 320 | |
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −6 000 | 1 896 | −75,99 | ||||
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 000 | 79 604 | 8,15 | 5,28 | 31 680 | 420 309 | |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 604 | 7 896 | −36,83 | |||
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 0 | −100,00 | |||
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 896 | 0 | −100,00 | |||
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −20 207 | 73 604 | −21,54 | 34,89 | −705 022 | 2 568 044 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 793 | 93 811 | −5,82 | 34,20 | −198 121 | 3 208 336 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 604 | 99 604 | 4,85 | 5,28 | 24 309 | 525 909 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 500 | 95 000 | 3,83 | 3,88 | 13 580 | 368 600 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 896 | 91 500 | 6,89 | 5,08 | 29 952 | 464 820 |
2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −14 000 | 5 896 | −70,37 | |||
2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −23 920 | 85 604 | −21,84 | 32,00 | −765 440 | 2 739 328 |
2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 14 000 | 109 524 | 14,66 | 5,08 | 71 120 | 556 382 |
2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 080 | 95 524 | −2,13 | 32,00 | −66 560 | 3 056 768 |
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 36 000 | 36 000 | |||||
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 000 | 97 604 | 6,55 | ||||
2015-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 8 500 | −5,56 | 23,94 | −11 970 | 203 490 |
2015-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 9 000 | −7,22 | 22,69 | −15 883 | 204 210 |
2015-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 400 | 91 604 | −2,55 | 23,93 | −57 432 | 2 192 084 |
2015-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 400 | 94 004 | −2,49 | 22,66 | −54 384 | 2 130 131 |
2015-09-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 9 700 | −3,96 | 34,96 | −13 984 | 339 112 |
2015-09-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 96 404 | −0,21 | 34,93 | −6 986 | 3 367 392 |
2015-09-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 96 604 | −0,31 | 33,55 | −10 065 | 3 241 064 |
2015-09-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 100 | 96 904 | −1,12 | 32,22 | −35 442 | 3 122 247 |
2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 46 000 | 98 004 | 88,45 | ||||
2015-08-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −20 000 | 3 500 | −85,11 | ||||
2015-08-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 20 000 | 52 004 | 62,49 | 3,88 | 77 600 | 201 776 | |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 19 896 | −7,44 | |||
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 0 | −100,00 | |||
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 10 100 | −1,94 | 31,69 | −6 338 | 320 069 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 10 100 | −1,94 | 31,69 | −6 338 | 320 069 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 10 300 | −7,21 | 30,99 | −24 792 | 319 197 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 11 100 | −3,48 | 31,95 | −12 780 | 354 645 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 400 | 32 204 | −4,17 | 31,00 | −43 400 | 998 324 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 33 604 | 5,00 | 5,08 | 8 128 | 170 708 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 210 | 32 004 | −3,64 | 31,60 | −38 236 | 1 011 326 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 790 | 33 214 | −7,75 | 30,83 | −86 016 | 1 023 988 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −800 | 21 496 | −3,59 | |||
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 4 000 | −50,00 | |||
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 11 500 | −1,71 | 33,22 | −6 644 | 382 030 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 11 700 | −7,87 | 32,31 | −32 310 | 378 027 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 32 004 | −2,44 | 33,22 | −26 576 | 1 063 173 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 800 | 32 804 | 2,50 | 5,08 | 4 064 | 166 644 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 32 004 | −0,31 | 32,74 | −3 274 | 1 047 811 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 900 | 32 104 | −10,83 | 32,29 | −125 931 | 1 036 638 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 22 296 | −6,70 | |||
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 8 000 | −33,33 | |||
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 12 700 | −3,05 | 31,07 | −12 428 | 394 589 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 13 100 | −7,09 | 31,57 | −31 570 | 413 567 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 600 | 32 004 | −14,89 | 31,57 | −176 792 | 1 010 366 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 37 604 | 4,44 | 5,08 | 8 128 | 191 028 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 23 896 | −6,28 | |||
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 12 000 | −25,00 | |||
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 400 | 14 100 | −9,03 | 32,20 | −45 080 | 454 020 |
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 600 | 32 004 | −14,89 | 32,41 | −181 496 | 1 037 250 |
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 37 604 | 4,44 | 5,08 | 8 128 | 191 028 |
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-04-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 16 000 | −20,00 | |||
2015-04-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 15 500 | −6,06 | 33,50 | −33 500 | 519 250 |
2015-04-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 000 | 32 004 | −11,11 | 33,53 | −134 120 | 1 073 094 |
2015-04-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-04-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −12 000 | 23 500 | −33,80 | ||||
2015-04-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 12 000 | 32 004 | 59,99 | 3,88 | 46 560 | 124 176 | |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −800 | 25 496 | −3,04 | |||
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 20 000 | −16,67 | |||
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 16 500 | −1,20 | 41,21 | −8 242 | 679 965 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 16 700 | −0,60 | 41,60 | −4 160 | 694 720 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −900 | 16 800 | −5,08 | 41,13 | −37 017 | 690 984 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 20 004 | −3,85 | 41,21 | −32 968 | 824 365 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 800 | 20 804 | 4,00 | 5,08 | 4 064 | 105 684 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −721 | 20 004 | −3,48 | 41,63 | −30 015 | 832 767 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 279 | 20 725 | −13,66 | 41,07 | −134 669 | 851 176 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 24 004 | 20,00 | 0,48 | 1 920 | 11 522 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 15 000 | 15 000 | |||||
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 26 296 | −5,74 | |||
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 24 000 | −14,29 | |||
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 17 700 | −1,67 | 41,38 | −12 414 | 732 426 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 18 000 | −3,74 | 40,63 | −28 441 | 731 340 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 18 700 | −2,09 | 40,92 | −16 368 | 765 204 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 20 004 | −7,41 | 40,21 | −64 336 | 804 361 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 21 604 | 8,00 | 5,08 | 8 128 | 109 748 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 20 004 | −0,99 | 42,07 | −8 414 | 841 568 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 001 | 20 204 | −4,72 | 41,40 | −41 441 | 836 446 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 799 | 21 205 | −11,66 | 40,66 | −113 807 | 862 195 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 24 004 | 20,00 | 0,48 | 1 920 | 11 522 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 28 000 | −12,50 | |||
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 27 896 | −5,42 | |||
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 19 100 | −4,98 | 41,60 | −41 600 | 794 560 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 20 100 | −1,95 | 41,70 | −16 680 | 838 170 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 486 | 24 004 | −9,38 | 41,81 | −103 940 | 1 003 607 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 514 | 22 490 | −6,31 | 41,23 | −62 422 | 927 263 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 24 004 | 20,00 | 0,48 | 1 920 | 11 522 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 20 004 | −7,41 | 41,78 | −66 848 | 835 767 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 21 604 | 8,00 | 5,08 | 8 128 | 109 748 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 32 000 | −11,11 | |||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 20 500 | −4,65 | 40,19 | −40 190 | 823 895 |
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 20 004 | −0,99 | 40,60 | −8 120 | 812 162 |
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 800 | 20 204 | −15,83 | 40,13 | −152 494 | 810 787 |
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 24 004 | 20,00 | 0,48 | 1 920 | 11 522 |
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −2 000 | 35 500 | −5,33 | ||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 2 000 | 20 004 | 11,11 | 3,88 | 7 760 | 77 616 | |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 29 496 | −11,94 | |||
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 21 500 | −2,27 | 43,73 | −21 865 | 940 195 |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 22 000 | −2,22 | 43,16 | −21 580 | 949 520 |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 065 | 18 004 | −5,58 | 43,88 | −46 732 | 790 016 |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 935 | 19 069 | −13,34 | 43,32 | −127 144 | 826 069 |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 22 004 | 22,22 | 5,08 | 20 320 | 111 780 |
2014-12-12 |
|
4/A | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 13 922 | −0,71 | 32,23 | −3 223 | 448 706 |
2014-12-12 |
|
4/A | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 900 | 14 022 | −11,93 | 31,47 | −59 793 | 441 272 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 082 | 36 000 | −10,18 | |||
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 22 500 | −1,32 | 34,51 | −10 353 | 776 475 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 22 800 | −2,98 | 33,42 | −23 394 | 761 976 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −907 | 19 940 | −4,35 | 34,54 | −31 328 | 688 728 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 175 | 20 847 | −13,22 | 33,54 | −106 490 | 699 208 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 082 | 24 022 | 20,47 | 0,48 | 1 959 | 11 531 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 504 | 33 496 | −4,30 | |||
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 414 | 0 | −100,00 | |||
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 23 500 | −1,67 | 33,70 | −13 480 | 791 950 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −600 | 23 900 | −2,45 | 32,64 | −19 584 | 780 096 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 317 | 19 940 | −10,41 | 33,59 | −77 828 | 669 785 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 601 | 22 257 | −6,71 | 32,43 | −51 920 | 721 795 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 504 | 23 858 | 6,73 | 5,08 | 7 640 | 121 199 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 414 | 22 354 | 12,11 | 1,80 | 4 345 | 40 237 |
2014-10-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 24 500 | −3,92 | 29,12 | −29 120 | 713 440 |
2014-10-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 918 | 19 940 | −16,42 | 29,10 | −114 014 | 580 254 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 082 | 2 414 | −62,84 | |||
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 25 500 | −0,78 | 30,41 | −6 082 | 775 455 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 25 700 | −3,02 | 29,27 | −23 416 | 752 239 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 193 | 23 858 | −4,76 | 30,28 | −36 124 | 722 420 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 889 | 25 051 | −10,34 | 29,17 | −84 272 | 730 738 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 082 | 27 940 | 17,11 | 1,80 | 7 348 | 50 292 |
2014-09-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 26 500 | −3,64 | 25,50 | −25 500 | 675 750 |
2014-09-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 000 | 23 858 | −14,36 | 25,47 | −101 880 | 607 663 |
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 6 496 | −38,11 | |||
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 27 500 | −3,51 | 25,79 | −25 790 | 709 225 |
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 27 858 | −0,71 | 26,40 | −5 280 | 735 451 |
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 800 | 28 058 | −11,93 | 25,80 | −98 040 | 723 896 |
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 31 858 | 14,36 | 1,80 | 7 200 | 57 344 |
2014-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 28 500 | −1,72 | 30,00 | −15 000 | 855 000 |
2014-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 27 858 | −6,70 | 29,53 | −59 060 | 822 647 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 316 | 10 496 | −29,14 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 684 | 40 081 | −4,03 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 29 000 | −4,92 | 29,82 | −44 730 | 864 780 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 29 858 | −0,33 | 30,25 | −3 025 | 903 204 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 900 | 29 958 | −16,45 | 29,77 | −175 643 | 891 850 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 316 | 35 858 | 13,68 | 1,80 | 7 769 | 64 544 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 684 | 31 542 | 5,64 | 0,48 | 808 | 15 140 |
2014-08-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −8 000 | 14 812 | −35,07 | ||||
2014-08-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 8 000 | 29 858 | 36,60 | 1,80 | 14 400 | 53 744 | |
2014-07-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −10 000 | 22 812 | −30,48 | ||||
2014-07-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 21 858 | 84,33 | 1,80 | 18 000 | 39 344 | |
2014-07-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 30 500 | −1,61 | 25,50 | −12 750 | 777 750 |
2014-07-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −33 | 11 858 | −0,28 | 26,78 | −884 | 317 557 |
2014-07-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 967 | 11 891 | −14,19 | 26,39 | −51 909 | 313 803 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −6 000 | 41 765 | −12,56 | |||
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −499 | 31 000 | −1,58 | 29,46 | −14 701 | 913 260 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 001 | 31 499 | −3,08 | 28,77 | −28 799 | 906 226 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 094 | 13 858 | −18,25 | 29,39 | −90 933 | 407 287 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 906 | 16 952 | −14,63 | 28,55 | −82 966 | 483 980 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 000 | 19 858 | 43,30 | 0,48 | 2 880 | 9 532 |
2014-06-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 32 500 | −1,52 | 34,13 | −17 065 | 1 109 225 |
2014-06-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 13 858 | −12,61 | 34,49 | −68 980 | 477 962 |
2014-06-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | −6 000 | 47 765 | −11,16 | |||
2014-06-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 33 000 | −4,35 | 33,25 | −49 875 | 1 097 250 |
2014-06-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 000 | 15 858 | −27,45 | 33,23 | −199 380 | 526 961 |
2014-06-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 000 | 21 858 | 37,84 | 0,48 | 2 880 | 10 492 |
2014-05-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −6 000 | 53 765 | −10,04 | |||
2014-05-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 000 | 15 858 | −27,45 | 30,97 | −185 820 | 491 122 |
2014-05-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 000 | 21 858 | 37,84 | 0,48 | 2 880 | 10 492 |
2014-05-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 34 500 | −4,17 | 30,99 | −46 485 | 1 069 155 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 36 000 | −1,37 | 31,68 | −15 840 | 1 140 480 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 15 858 | −0,63 | 32,23 | −3 223 | 511 103 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 900 | 15 958 | −10,64 | 31,47 | −59 793 | 502 198 |
2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 36 500 | −2,67 | 35,75 | −35 750 | 1 304 875 |
2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 936 | 15 922 | −10,84 | 36,08 | −69 851 | 574 466 |
2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 064 | 17 858 | −10,36 | 35,64 | −73 561 | 636 459 |
2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 | |||||
2013-09-18 | 3 | XLRN |
ACCELERON PHARMA INC
Common Stock |
19 922 | ||||||||
2013-09-18 | 3 | XLRN |
ACCELERON PHARMA INC
Common Stock |
37 500 |